Q3 2023 · 13F-HR
Nan Fung Group Holdings Ltdholdings as filed
Filed 2023-11-13 · accession 0001012975-23-000456
$123.5M
Reported value
39
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 48576A100 | — | KARUNA THERAPEUTICS INC | $38.2M | 30.9% | 225,688 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $16.4M | 13.3% | 119,196 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $12.1M | 9.78% | 368,665 | Common | SOLE |
| 81181C104 | — | SEAGEN INC | $10.0M | 8.09% | 47,096 | Common | SOLE |
| H5870P102 | OCS | OCULIS HOLDING AG | $6.7M | 5.40% | 606,684 | Common | SOLE |
| 83444K105 | SLGCUSD | SOMALOGIC INC | $4.1M | 3.28% | 1,696,558 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA PLC | $3.9M | 3.15% | 859,892 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $3.6M | 2.95% | 106,680 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $3.2M | 2.62% | 137,038 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $3.2M | 2.56% | 184,739 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $2.3M | 1.83% | 234,573 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $2.2M | 1.75% | 12,022 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $2.1M | 1.69% | 182,280 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $1.8M | 1.50% | 32,022 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $1.6M | 1.29% | 753,550 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $1.4M | 1.14% | 64,200 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $1.2M | 0.98% | 1,166,952 | Common | SOLE |
| 69404D108 | PACB | PACIFIC BIOSCIENCES CALIF IN | $1.1M | 0.92% | 136,655 | Common | SOLE |
| 753018100 | RANI | RANI THERAPEUTICS HLDGS INC | $1.1M | 0.87% | 493,584 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $918,605 | 0.74% | 40,070 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $775,496 | 0.63% | 49,082 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $717,623 | 0.58% | 47,150 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $703,031 | 0.57% | 1,430 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $650,492 | 0.53% | 47,936 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $624,867 | 0.51% | 29,984 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $550,400 | 0.45% | 40,000 | Common | SOLE |
| 23306J101 | — | DBV TECHNOLOGIES S A | $504,492 | 0.41% | 370,950 | Common | SOLE |
| 04746L104 | — | ATHIRA PHARMA INC | $363,600 | 0.29% | 180,000 | Common | SOLE |
| 270087208 | — | EARGO INC | $321,100 | 0.26% | 147,904 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $319,855 | 0.26% | 3,615 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $223,817 | 0.18% | 4,425 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $201,360 | 0.16% | 41,950 | Common | SOLE |
| N01045108 | — | AFFIMED N V | $178,004 | 0.14% | 372,472 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $126,357 | 0.10% | 17,847 | Common | SOLE |
| 36338D108 | GRTX | GALERA THERAPEUTICS INC | $107,375 | 0.09% | 613,223 | Common | SOLE |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $57,597 | 0.05% | 12,521 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $53,591 | 0.04% | 62,106 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $35,320 | 0.03% | 19,622 | Common | SOLE |
| 157085101 | CERS | CERUS CORP | $22,959 | 0.02% | 14,172 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.